Migraine Trials in Long Beach, United States
Conditions / Migraine / Long Beach, United States
Research into Migraine spans multiple therapeutic approaches and trial phases.
22 total trials for this combination
Showing top 10 of 22 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04396236 | A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine | TERMINATED | PHASE3 |
| NCT04396574 | A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine | TERMINATED | PHASE3 |
| NCT03901482 | A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine | COMPLETED | PHASE3 |
| NCT02629861 | Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine | COMPLETED | PHASE3 |
| NCT02621931 | Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine | COMPLETED | PHASE3 |
| NCT04804033 | A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention | TERMINATED | PHASE2/PHASE3 |
| NCT02638103 | Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine | COMPLETED | PHASE3 |
| NCT04571060 | Randomized Trial in Adult Participants With Acute Migraines | COMPLETED | PHASE3 |
| NCT06616194 | A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine | RECRUITING | PHASE3 |
| NCT05125302 | Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) | RECRUITING | PHASE3 |